Next Article in Journal
Prion Disease and the Innate Immune System
Next Article in Special Issue
Development of Live-Attenuated Influenza Vaccines against Outbreaks of H5N1 Influenza
Previous Article in Journal
Host Cell Factors in Filovirus Entry: Novel Players, New Insights
Previous Article in Special Issue
Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults
Viruses 2012, 4(12), 3363-3388; doi:10.3390/v4123363

Notes on Article Versions

NoteDate
article html file updated24 January 2013 09:20 CET
article html file updated7 February 2013 16:56 CET
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert